ALK ABELLÓ AS has a total of 14 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TRIACT THERAPEUTICS INC, EGIS PHARMACEUTICALS PLC and ATRIVA THERAPEUTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 3 | |
#4 | Poland | 1 | |
#5 | Singapore | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Lund Kaare | 4 |
#2 | Brimnes Jens | 4 |
#3 | Christensen Lars Harder | 3 |
#4 | Arshad Syed Hasan | 2 |
#5 | Ortego Félix | 2 |
#6 | Lundegaard Claus | 2 |
#7 | Würtzen Peter Adler | 2 |
#8 | Schrøder Dorte Ellen | 2 |
#9 | Roberts Graham Colin | 2 |
#10 | Jacobi Henrik Hugo | 2 |
Publication | Filing date | Title |
---|---|---|
WO2015131053A1 | Polypeptides derived from phl p and methods and uses thereof for immune response modulation | |
EP2952200A1 | Allergen for prophylactic treatment of allergy |